PRVA News and Press, Privia Health Group Inc. From 08/03/23

Practice Collections +13.7% compared to 2Q’22 Implemented Providers +9.3% compared to 2Q’22 Company Updated Full Year 2023 Guidance ARLINGTON, Va., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced fi...

ARLINGTON, Va., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) a national physician enablement company, announced it has signed a definitive agreement to enter the state of Washington in partnership with Walla Walla Clinic, a multi-specialty practice with more than 50 ...

ARLINGTON, Va., July 31, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced the election of David S. Wichmann and Pamela O. Kimmet to its Board of Directors, effective August 1, 2023. Jeff Bernstein, Managing Director of Goldman Sachs, will resign from the Board eff...

ARLINGTON, Va., July 11, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its second quarter and six-month periods ended June 30, 2023 before market open on Thursday, August 3, 2023. The press release is expecte...

Partnership builds on Velocity’s embedded site model strategy and expands access to clinical trials for Privia Health patients and providers First site will open in Abilene, TX DURHAM, N.C., July 11, 2023 (GLOBE NEWSWIRE) -- Velocity Clinical Research (“Velocity ...

Distinguished Healthcare Leader Adam Boehler to Join Board Incoming CEO Parth Mehrotra to Join Board Will Sherrill Resigns from Board ARLINGTON, Va,, June 29, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that Adam Boehler, founder a...

eXp World Holdings & Privia Health Group Set to Join S&P SmallCap 600 eXp World Holdings & Privia Health Group Set to Join S&P SmallCap 600 PR Newswire NEW YORK , June 7, 2023 /PRNewswire/ -- S&P Dow Jones Indices will make the follow...

2023-05-31 18:35:08 ET Summary PRVA had a strong start to the year with solid core operations and expansion into new markets, leading to a reaffirmed FY23 guidance. The platform contribution in 1Q23 exceeded expectations, with potential for modest upside surprise to the FY23 guida...

2023-05-04 09:22:53 ET Privia Health Group ( NASDAQ: PRVA ) prices underwritten secondary offering of ~31.3M shares at a price of $22.00 per share. The company will not receive any of the proceeds from the sale of the shares and will bear the costs associated wi...

- Investors include Durable Capital Partners LP and Rubicon Founders LLC ARLINGTON, Va., May 04, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA), a technology-driven, national physician enablement company, today announced the upsized pricing of an underwritten secondary ...